Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma

Cancer

Volumn 79, Issue 12, 1997, Pages 2385-2390

  Li, Benjamin D L ^a   Liu, Li ^b   Dawson, Mathew ^a   De Benedetti, Arrigo ^b  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Breast carcinoma; eIF4E; In situ staining; Initiation factor; Overexpression; Prognosis; Western blot analysis

Indexed keywords

INITIATION FACTOR 2;

ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SYNTHESIS; RNA TRANSLATION; TRANSLATION INITIATION;

BLOTTING, WESTERN; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; HUMANS; NEOPLASM PROTEINS; NEOPLASM STAGING; PEPTIDE INITIATION FACTORS;

EID: 0030940199     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970615)79:12<2385::AID-CNCR13>3.0.CO;2-N     Document Type: Article

References (28)

1. Hershey JW. Translational control in mammalian cells. Annu Rev Biochem 1991;60:717-55.
2. Rhoads RE. Regulation of eukaryotic protein synthesis by initiation factors. J Biol Chem 1993;268:3017-20.
3. Sonenberg N. Regulation of translation and cell growth by eIF4E. Biochimie 1994;76:839-46.
4. De Benedetti A, Joshi-Barve S, Rinker-Schaeffer C, Rhoads RE. Expression of antisense RNA against initiation factor eIF4E mRNA in HeLa cells results in lenghtened cell division times, diminished translation rates, and reduced levels of both eIF4E and p220 component of eIF4E. Mol Cell Biol 1991;11(11):5435-45.
5. Rhoads RE, Joshi-Bavre S, Rinker-Schaeffer CW. Mechanism of action and regulation of protein synthesis initiation factor 4E: effects on mRNA discrimination, cellular growth rate, and oncogenesis. Prog Nucleic Acid Res Mol Biol 1993;46:183-219.
6. Duncan R, Milburn SC, Herhey JB. Regulated phosphorylation and low abundance of HeLa cell initiation factor eIF4E suggest a role in translational control. J Biol Chem 1987;262:380-8.
7. Lodish HF. Model for the regulation of mRNA translation applied to haemoglobin synthesis. Nature 1974;251:385-8.
8. Pelletier J, Sonenberg N. The involvement of mRNA secondary structure in protein synthesis. Biochem Cell Biol 1987;65:576-81.
9. Kerekatte V, Smiley K, Hu B, Smith A, Gelder F, De Benedetti A. The proto-oncogene/translation factor eIF4E: a survey of its expression in breast carcinomas. Int J Cancer 1995;64:27-31.
10. Rosenwald IB, Lazaris-Karatzas A, Sonenberg N, Schmidt EV. Elevated levels of cyclin D1 in response to increased expression of eukaryotic initiation factor 4E. Mol Cell Biol 1993;13(12):7358-63.
11. Kevil CG, De Benedetti A, Payne DK, Coe LL, Laroux FS, Alexander JS. Translational regulation of vascular permeability factor by eukaryotic initiation factor 4E: implications for tumor angiogenesis. Int J Cancer 1996;65:785-90.
12. Kevil CG, Carter P, Hu B, De Benedetti A. Translational enhancement of FGF-2 by eIF4E factors, and alternate utilization of CUG and AUG codons for translation initiation. Oncogene 1995;11:2339-48.
13. Bernstein J, Shefler I, Elroy-Stein O. The translational repression mediated by the Platelet-derived Growth Factor 2/c-sis mRNA leader is relieved during megakaryotytic differentiation. J Biol Chem 1995;270:10559-65.
14. Jones RM, Branda J, Johnston KA, Polymenis M, Gadd M, Rustgi A, et al. An essential E Box in the promoter of the gene encoding the mRNA Cap-binding protein (eukaryotic initiation factor 4E) is a target for activation by c-myc. Mol Cell Biol 1996;16(9):4754-64.
15. Lazaris-Karatzas A. Montine K, Sonenberg M. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature 1990;345:544-7.
16. Schantz LM, Pegg AE. Overexpression of ornithinedecarboxylase caused relief of translational repression is associated with neoplastic transformation. Cancer Res 1994;54:2313-6.
17. De Benedetti A, Rhoads RE. Overexpression of eukaryotic protein synthesis initiation factor 4E in HeLa cells results in aberrant growth and morphology. Proc Natl Acad Sci USA 1990;87:8212-6.
18. De Benedetti A, Joshi B, Graff JR, Zimmer SG. CHO cells transformed by the translational factor eIF4E display increased c-myc expression, but require overexpression of Max for tumorigenicity. Mol Cell Diff 1994;2(4):347-71.
19. Rinker-Schaeffer CW, Graff JR, De Benedetti A, Zimmer SG, Rhoads RE. Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblast. Int J Cancer 1993;55:841-7.
20. Graff JR, Boghaert ER, De Benedetti A, Tudor DL, Zimmer C. Reduction in translation initiation factor 4E decreases the malignancy of ras-transformed cloned rat embryo fibroblasts. Int J Cancer 1995;60:255-63.
21. Menezes CO, De Benedetti A, Abreo F. A survey of the protooncogene/translation factor in head and neck squamous cell cancers [abstract]. Otolaryngol Head Neck Surg 1996;115(2):P72.
22. American Joint Committee on Cancer Breast. In: Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, editors. Handbook for staging of cancer, from the manual for staging of cancer. 4TH edition. Philadelphia: J.B. Lippincott, 1993:161-7.
23. Fishel R, Lescoe MK, Rao MRS, Copeland NG, Jenkins NA, Garber J, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
24. Welsh GI, Miyamoto S, Price NT, Safer B, Proud CG. T-cell activation leads to rapid stimulation of translation initiation factor eIF4E and inactivation of glycogen synthase kinase-3. J Biol Chem 1996;271(19):11410-3.
25. Frykberg ER, Bland KI. Management of in situ and minimally invasive breast cancer. World J Surg 1994;18:45-57.
26. Liu L, Li BDL, Abreo F, Kevil CG, De Benedetti A. The role of eIF4E in vascularization and progression of breast cancer. In: Jackson RJ, Mathews MB, Wickens M, editors. Translational control. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1996:181.
27. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
28. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.